text
"['\nXII. 상세표\n1. 연결대상 종속회사 현황(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n상호\n설립일\n주소\n주요사업\n최근사업연도말자산총액\n지배관계 근거\n주요종속회사 여부\n㈜가산\n2007.07\n경기 안성시 원곡면 지산길 55-153\n식품첨가물 제조, 도소매\n8,235\n기업의결권의 과반수 소유(기업회계기준서 1110호)\n해당없음\n연변광동제약유한공사\n2009.06\nLiangshui Town, Tumen City, Jilin Province,China\n한약재 농축액제품의 가공과 판매\n15,184\n실질적 지배력(기업회계기준서 1110호)\n해당없음\nKwangdong Vina Co.,Ltd.\n2010.09.\n51- Ky Dong, Thanh Khe Dong, Thanh Khe Distric, Da Nang City,Vietnam\n석재업\n1,197\n기업의결권의 과반수 소유(기업회계기준서 1110호)\n해당없음\n코리아이플랫폼(주)\n2000.06\n서울 강남구 개포로 619\n소모성자재구매대행\n179,793\n상동\n주요종속회사\n연태애매락상무유한공사\n2008.07\n33 Changjiang Road, Kaifaqu(Etdz),Yantai City, ShangDong, China\n상품도매업\n2,122\n상동\n해당없음\n소주애매락상무유한공사\n2012.03\n8 Suzhoudadaoxi, Gongyeyuanqu,Suzhou City, Jiangsu, China\n상품도매업\n6,756\n상동\n해당없음\n케이디인베스트먼트(주)\n2019.05\n서울시 강남구 테헤란로 420\n금융업, 서비스업\n22,298\n상동\n해당없음\n케이디바이오투자조합1호\n2019.09\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n17,367\n상동\n해당없음\n케이디바이오투자조합2호\n2020.05\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n9,148\n상동\n해당없음\n케이디바이오투자조합3호\n2020.09\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n1,028\n상동\n해당없음\n2. 계열회사 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 12월 31일\n)\n(단위 : 사)\n상장여부\n회사수\n기업명\n법인등록번호\n상장\n-\n-\n-\n-\n-\n비상장\n10\n(주)가산\n134611-0035340\n코리아이플랫폼(주)\n110111-2008921\n케이디인베스트먼트(주)\n110111-7099082\n케이디바이오투자조합1호\n829-80-01339\n케이디바이오투자조합2호\n754-80-01791\n케이디바이오투자조합3호\n757-80-01693\n연변광동제약유한공사\n해외법인\nKwangdong Vina Co., Ltd.\n해외법인\n연태애매락상무유한공사\n해외법인\n소주애매락상무유한공사\n해외법인\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2022년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n가산\n비상장\n2007.07.27\n경영참여\n100\n230,000\n100.0\n2,300\n-\n-\n-\n230,000\n100.0\n2,300\n8,235\n504\n연변광동제약\n비상장\n2009.09.30\n""\n1,600\n-\n50.0\n4,992\n-\n-\n-\n-\n50.0\n4,992\n15,184\n1,191\n코리아이플랫폼\n비상장\n2015.03.17\n""\n40,738\n4,735,861\n64.6\n42,981\n3,000\n11\n-\n4,738,861\n64.6\n42,992\n179,793\n6,467\nKD인베스트먼트\n비상장\n2019.05.07\n""\n20,000\n4,000,000\n100.0\n20,014\n-\n-\n-\n4,000,000\n100.0\n20,014\n22,298\n-434\nKwangdong Vina Co.,Ltd\n비상장\n2019.05.31\n""\n1,476\n-\n99.9\n1,128\n-\n-\n-\n-\n99.9\n1,128\n1,197\n23\n케이디바이오투자조합1호\n비상장\n2019.09.24\n""\n2,500\n145\n83.3\n14,500\n-\n-\n-\n145\n83.3\n14,500\n17,367\n-4,765\n케이디바이오투자조합2호\n비상장\n2020.05.07\n""\n9,000\n90\n83.3\n9,000\n-\n-\n-\n90\n83.3\n9,000\n9,148\n-271\n케이디바이오투자조합3호\n비상장\n2020.09.15\n""\n550\n55\n50.0\n550\n-\n-\n-\n55\n50.0\n550\n1,028\n-36\n케이디엠코\n비상장\n2021.12.07\n""\n6\n1,200\n20.0\n6\n-\n-\n-\n1,200\n20.0\n6\n-\n-\nOxford CancerBiomarkers Limited\n비상장\n2019.05.20\n""\n3,036\n1,431\n11.5\n3,103\n-\n-\n-\n1,431\n11.5\n3,103\n-\n-\n케이디재산투자조합2호\n비상장\n2020.09.15\n단순투자\n800\n80\n38.1\n800\n-\n-\n-\n80\n38.1\n800\n-\n-\n케이디바이오투자조합5호\n비상장\n2021.05.20\n""\n1,500\n1,500\n53.6\n1,500\n-\n-\n-\n1,500\n53.6\n1,500\n-\n-\n케이디바이오투자조합6호\n비상장\n2022.09.08\n""\n500\n-\n-\n-\n50\n500\n-\n50\n45.5\n500\n-\n-\n케이디유온신성장1호투자조합\n비상장\n2022.06.02\n""\n1,000\n-\n-\n-\n100\n1,000\n-\n100\n10.0\n1,000\n-\n-\n씨엘팜\n비상장\n2011.05.06\n""\n2,000\n84,000\n11.0\n-\n-\n-\n-\n84,000\n11.0\n-\n-\n-\n비트로시스\n비상장\n2017.07.31\n""\n1,005\n670,000\n9.4\n1,005\n-\n-\n-\n670,000\n9.4\n1,005\n-\n-\n가이아바이오투자조합\n비상장\n2018.09.03\n""\n2,000\n-\n32.8\n2,000\n-\n-\n-\n-\n32.8\n2,000\n-\n-\n바이넥스\n상장\n2020.06.26\n""\n5,279\n390,000\n1.2\n5,279\n-\n-\n-\n390,000\n1.2\n5,279\n298,410\n12,365\n신송홀딩스\n상장\n2015.06.01\n""\n3,101\n332,000\n2.8\n1,723\n-222,000\n-3,217\n2,153\n110,000\n0.9\n659\n242,350\n1,576\n\xa0맥쿼리한국인프라투융자회사\n상장\n2019.05.31\n""\n1,167\n223,926\n0.1\n3,146\n-\n-\n-672\n223,926\n0.1\n2,474\n-\n-\n금호에이치티\n상장\n2021.11.22\n""\n347\n144,919\n0.1\n307\n-\n-\n-178\n144,919\n0.1\n129\n426,634\n-22,586\n진양개발 우선주\n비상장\n2010.05.13\n""\n450\n900\n-\n450\n-\n-\n-\n900\n-\n450\n-\n-\n아트플레쉬\n비상장\n2018.07.06\n""\n1,507\n707,000\n15.3\n507\n-\n-\n-\n707,000\n15.3\n507\n-\n-\n\xa0 쿼드메이슨\n비상장\n2022.04.27\n""\n1,999\n-\n-\n-\n817\n1,999\n-\n-\n-\n1,999\n-\n-\n\xa0 디에스피이알파\n비상장\n2022.04.28\n""\n5,000\n-\n-\n-\n5,000,000,000\n5,000\n68\n5,000,000,000\n7.1\n5,068\n-\n-\n합 계\n-\n-\n115,291\n-\n5,293\n1,371\n-\n-\n121,955\n-\n-\n※ 주식 평가손실에 대한 사항은 다음과 같습니다.\n회사명\n상장여부\n감액사유\n감액금액(백만원)\n맥쿼리한국인프라투융자회사\n상장\n주가하락에 따른 평가손실 반영\n672\n금호에이치티\n상장\n주가하락에 따른 평가손실 반영\n178\n']"
